BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6315452)

  • 1. Identification and subclassification of rat adipocyte beta-adrenoceptors using (+/-)-[125I]cyanopindolol.
    Bojanic D; Nahorski SR
    Eur J Pharmacol; 1983 Sep; 93(3-4):235-43. PubMed ID: 6315452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of propranolol-resistant (-)-[125I]-cyanopindolol binding sites in rat soleus muscle.
    Roberts SJ; Molenaar P; Summers RJ
    Br J Pharmacol; 1993 Jun; 109(2):344-52. PubMed ID: 8102926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific non-beta-adrenergic binding sites for 125I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts.
    Bjørnerheim R; Golf S; Hansson V
    Cardiovasc Res; 1991 Sep; 25(9):764-73. PubMed ID: 1666020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes.
    Sillence MN; Moore NG; Pegg GG; Lindsay DB
    Br J Pharmacol; 1993 Aug; 109(4):1157-63. PubMed ID: 8104645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible antagonism of beta-adrenoceptors with para-amino-benzyl-carazolol provides further evidence for an atypical rat adipocyte beta-adrenoceptor.
    Bojanic D; Nahorski SR
    J Recept Res; 1984; 4(1-6):21-35. PubMed ID: 6098653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical responses of rat ileum to pindolol, cyanopindolol and iodocyanopindolol.
    Hoey A; Jackson C; Pegg G; Sillence M
    Br J Pharmacol; 1996 Feb; 117(4):712-6. PubMed ID: 8646418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):1-12. PubMed ID: 3002805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of propranolol and iodocyanopindolol to isolated cells, homogenates and plasma membranes of rat liver, lung, kidney and heart.
    Zini R; Gault I; Ledewyn S; D'Athis P; Tillement JP
    Biochem Pharmacol; 1983 Nov; 32(22):3375-80. PubMed ID: 6316980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of 125I-iodohydroxybenzylpindolol to cerebral membranes: association with 5-hydroxytryptamine recognition sites as well as beta-adrenoceptors.
    Willcocks AL; Nahorski SR
    Biochem Pharmacol; 1983 Nov; 32(22):3311-9. PubMed ID: 6316978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of beta-adrenergic subtypes in immature rabbit bone marrow erythroblasts.
    Setchenska MS; Bonanou-Tzedaki SA; Arnstein HR
    Biochem Pharmacol; 1986 Nov; 35(21):3679-84. PubMed ID: 2877667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A beta adrenoceptor with atypical characteristics is involved in the relaxation of the rat small intestine.
    van der Vliet A; Rademaker B; Bast A
    J Pharmacol Exp Ther; 1990 Oct; 255(1):218-26. PubMed ID: 1976798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical and atypical binding sites for beta-adrenoceptor ligands and activation of adenylyl cyclase in bovine skeletal muscle and adipose tissue membranes.
    Sillence MN; Matthews ML
    Br J Pharmacol; 1994 Mar; 111(3):866-72. PubMed ID: 7912629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical characteristics of the beta-adrenoceptor mediating cyclic AMP generation and lipolysis in the rat adipocyte.
    Bojanic D; Jansen JD; Nahorski SR; Zaagsma J
    Br J Pharmacol; 1985 Jan; 84(1):131-7. PubMed ID: 2983800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of catecholamine-mediated relaxations in rat isolated gastric fundus: evidence for an atypical beta-adrenoceptor.
    McLaughlin DP; MacDonald A
    Br J Pharmacol; 1991 Jun; 103(2):1351-6. PubMed ID: 1679358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of three beta-adrenoceptor subtypes in white fat cells of various mammalian species.
    Langin D; Portillo MP; Saulnier-Blache JS; Lafontan M
    Eur J Pharmacol; 1991 Jul; 199(3):291-301. PubMed ID: 1680716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of human platelet beta-adrenergic receptors using 125I-labeled cyanopindolol and 125I-labeled hydroxybenzylpindolol.
    Steer ML; Atlas D
    Biochim Biophys Acta; 1982 Apr; 686(2):240-4. PubMed ID: 6282327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-homogeneous distribution of beta 1- and beta 2-adrenoceptors in various human tissues.
    Sano M; Yoshimasa T; Yagura T; Yamamoto I
    Life Sci; 1993; 52(12):1063-70. PubMed ID: 8383268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoradiographic localization of beta-adrenoceptors in pig lung using [125I]-iodocyanopindolol.
    Goldie RG; Papadimitriou JM; Paterson JW; Rigby PJ; Spina D
    Br J Pharmacol; 1986 Jul; 88(3):621-8. PubMed ID: 3017489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenergic receptors in DMBA-induced rat mammary tumors: correlation with progesterone receptor and tumor growth.
    Marchetti B; Spinola PG; Plante M; Poyet P; Folléa N; Pelletier G; Labrie F
    Breast Cancer Res Treat; 1989 Jul; 13(3):251-63. PubMed ID: 2569332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of rat liver beta-adrenoceptors during perinatal development as determined by [125I]-iodopindolol radioligand binding assays.
    Snell K; Evans CA
    Br J Pharmacol; 1988 Apr; 93(4):817-26. PubMed ID: 2839263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.